메드페이스 홀딩스, Inc.
DE ˙ DB ˙ US58506Q1094
€394.00 ↑6.10 (1.57%)
2026-06-04
주가
SecurityDE:01P / Medpace Holdings, Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership504,668 shares
Latest Disclosed Value $ 242,336,527
Renaissance Technologies Llc reports 8.32% increase in ownership of 01P / Medpace Holdings, Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 504,668 shares of Medpace Holdings, Inc. (DE:01P) valued at $207,973,683 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 465,908 shares of Medpace Holdings, Inc.. This represents a change in shares of 8.32% during the quarter. The current value of the position is $198,839,192 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F MEDPACE HLDGS COM 58506Q109 504,668 38,760 8.32 242,337 -7.39 0.3791
2026-02-12 2025-12-31 13F MEDPACE HLDGS COM 58506Q109 465,908 -27,680 -5.61 261,677 3.11 0.4059
2025-11-13 2025-09-30 13F MEDPACE HLDGS COM 58506Q109 493,588 -184,500 -27.21 253,783 19.25 0.3350
2025-08-13 2025-06-30 13F MEDPACE HLDGS COM 58506Q109 678,088 100,400 17.38 212,825 20.91 0.2831
2025-05-14 2025-03-31 13F MEDPACE HLDGS COM 58506Q109 577,688 24,100 4.35 176,016 -4.30 0.2664
2025-02-13 2024-12-31 13F MEDPACE HLDGS COM 58506Q109 553,588 61,100 12.41 183,919 11.88 0.2723
2024-11-13 2024-09-30 13F MEDPACE HLDGS COM 58506Q109 492,488 48,900 11.02 164,392 -10.02 0.2472
2024-08-09 2024-06-30 13F MEDPACE HLDGS COM 58506Q109 443,588 122,800 38.28 182,692 141,520.93 0.3099
2024-05-13 2024-03-31 13F MEDPACE HLDGS COM 58506Q109 320,788 69,400 27.61 130 67.53 0.2038
2024-02-13 2023-12-31 13F MEDPACE HLDGS COM 58506Q109 251,388 -7,800 -3.01 77 24.19 0.1193
2023-11-14 2023-09-30 13F MEDPACE HLDGS COM 58506Q109 259,188 48,300 22.90 63 24.00 0.1070
2023-08-11 2023-06-30 13F MEDPACE HLDGS COM 58506Q109 210,888 -86,600 -29.11 51 -9.09 0.0730
2023-05-12 2023-03-31 13F MEDPACE HLDGS COM 58506Q109 297,488 93,500 45.84 56 27.91 0.0742
2023-02-13 2022-12-31 13F MEDPACE HLDGS COM 58506Q109 203,988 -62,200 -23.37 43 -99.90 0.0593
2022-11-14 2022-09-30 13F MEDPACE HLDGS COM 58506Q109 266,188 -88,700 -24.99 41,837 -21.23 0.0592
2022-08-12 2022-06-30 13F MEDPACE HLDGS COM 58506Q109 354,888 -25,200 -6.63 53,116 -14.58 0.0629
2022-05-13 2022-03-31 13F MEDPACE HLDGS COM 58506Q109 380,088 -14,800 -3.75 62,179 -27.65 0.0730
2022-02-11 2021-12-31 13F MEDPACE HLDGS COM 58506Q109 394,888 -19,000 -4.59 85,943 9.70 0.1069
2021-11-12 2021-09-30 13F MEDPACE HLDGS COM 58506Q109 413,888 -8,400 -1.99 78,341 5.03 0.1012
2021-08-13 2021-06-30 13F MEDPACE HLDGS COM 58506Q109 422,288 -42,100 -9.07 74,589 -2.09 0.0931
2021-05-13 2021-03-31 13F MEDPACE HLDGS COM 58506Q109 464,388 -139,400 -23.09 76,183 -9.36 0.0948
2021-02-10 2020-12-31 13F MEDPACE HLDGS COM 58506Q109 603,788 -234,300 -27.96 84,047 -10.26 0.0913
2020-11-13 2020-09-30 13F MEDPACE HLDGS COM 58506Q109 838,088 -35,332 -4.05 93,656 15.27 0.0935
2020-08-13 2020-06-30 13F MEDPACE HLDGS COM 58506Q109 873,420 53,732 6.56 81,246 35.07 0.0701
2020-05-14 2020-03-31 13F MEDPACE HLDGS COM 58506Q109 819,688 233,600 39.86 60,149 22.09 0.0584
2020-02-13 2019-12-31 13F MEDPACE HLDGS COM 58506Q109 586,088 112,100 23.65 49,267 23.68 0.0379
2019-11-13 2019-09-30 13F MEDPACE HLDGS COM 58506Q109 473,988 130,888 38.15 39,834 77.47 0.0337
2019-08-12 2019-06-30 13F MEDPACE HLDGS COM 58506Q109 343,100 101,000 41.72 22,446 57.22 0.0198
2019-05-14 2019-03-31 13F MEDPACE HLDGS COM 58506Q109 242,100 -246,400 -50.44 14,277 -44.78 0.0130
2019-02-12 2018-12-31 13F MEDPACE HLDGS COM 58506Q109 488,500 -296,400 -37.76 25,856 -45.01 0.0283
2018-11-13 2018-09-30 13F MEDPACE HLDGS COM 58506Q109 784,900 446,000 131.60 47,023 222.67 0.0483
2018-08-13 2018-06-30 13F/A-1 MEDPACE HLDGS COM 58506Q109 338,900 229,200 208.93 14,573 280.50 0.0159
2018-08-13 2018-06-30 13F MEDPACE HLDGS COM 58506Q109 109,700 3,830
2018-05-14 2018-03-31 13F MEDPACE HLDGS COM 58506Q109 109,700 -73,800 -40.22 3,830 -42.44 0.0042
2018-02-13 2017-12-31 13F MEDPACE HLDGS COM 58506Q109 183,500 98,400 115.63 6,654 145.08 0.0073
2017-11-13 2017-09-30 13F MEDPACE HLDGS COM 58506Q109 85,100 85,100 2,715 0.0032
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.